Inositol 1,4,5-trisphosphate receptor 1 mutation perturbs glucose homeostasis and enhances susceptibility to diet-induced diabetes

Journal of Endocrinology

Volumn 210, Issue 2, 2011, Pages 209-217

  Ye, Risheng ^a,c   Ni, Min ^a,d   Wang, Miao ^a,c   Luo, Shengzhan ^a,e   Zhu, Genyuan ^a   Chow, Robert H ^b   Lee, Amy S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTACTIN; CONTACTIN 4; GLUCOSE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR 1; INSULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 6; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; GENE LOCUS; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE; ANIMAL; FAT INTAKE; GENETICS; HOMEOSTASIS; METABOLISM; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DISEASE SUSCEPTIBILITY; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, TRANSGENIC; MUTATION;

EID: 80052556278     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0012     Document Type: Article

References (27)

1. Cota D, Proulx K & Seeley RJ 2007 The role of CNS fuel sensing in energy and glucose regulation. Gastroenterology 132 2158-2168.
2. Cottrell CE, Bir N, Varga E, Alvarez CE, Bouyain S, Zernzach R, Thrush DL, Evans J, Trimarchi M, Butter EM et al. 2011 Contactin 4 as an autism susceptibility locus. Autism Research 4 189-199.
3. De Smedt H, Missiaen L, Parys JB, Henning RH, Sienaert I, Vanlingen S, Gijsens A, Himpens B & Casteels R 1997 Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. Biochemical Journal 322 575-583.
4. Dong D, Dubeau L, Bading J, Nguyen K, Luna M, Yu H, Gazit-Bornstein G, Gordon EM, Gomer C, Hall FL et al. 2004 Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Human Gene Therapy 15 553-561.
5. Dyachok O & Gylfe E 2004 Ca(2+)-induced Ca(2+) release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic beta-cells. Journal of Biological Chemistry 279 45455-45461.
6. 2+ release by activation of inositol 1,4,5-trisphosphate receptors in primary pancreatic beta-cells. Cell Calcium 36 1-9.
7. 2+ release channels in neurological diseases. Pflügers Archiv: European Journal of Physiology 460 481-494.
8. 2+ release channels. Physiological Reviews 87 593-658.
9. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, Kitaguchi T, Takahashi-Iwanaga H, Noda T, Aruga J et al. 2005 IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309 2232-2234.
10. Healy JA, Nilsson KR, Hohmeier HE, Berglund J, Davis J, Hoffman J, Kohler M, Li LS, Berggren PO,Newgard CB et al. 2010 Cholinergic augmentation of insulin release requires ankyrin-B. Science Signaling 3 ra19.
11. Kim JK 2009 Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. Methods in Molecular Biology 560 221-238.
12. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R & Berns A 1991 Simplified mammalian DNA isolation procedure. Nucleic Acids Research 19 4293.
13. Lee B & Laychock SG 2001 Inositol 1,4,5-trisphosphate receptor isoform expression in mouse pancreatic islets: effects of carbachol. Biochemical Pharmacology 61 327-336.
14. van de Leemput J, Chandran J, Knight MA, Holtzclaw LA, Scholz S, Cookson MR, Houlden H, Gwinn-Hardy K, Fung HC, Lin X et al. 2007 Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genetics 3 e108.
15. Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T, Shaughnessy JD Jr, Jenkins NA & Copeland NG 1999 Leukaemia disease genes: large-scale cloning and pathway predictions. Nature Genetics 23 348-353.
16. Luo S, Baumeister P, Yang S, Abcouwer SF & Lee AS 2003 Induction of Grp78/BiP by translational block: activation of the Grp78 promoter by ATF4 through an upstream ATF/CRE site independent of the endoplasmic reticulum stress elements. Journal of Biological Chemistry 278 37375-37385.
17. Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M et al. 1996 Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379 168-171.
18. Prentki M & Nolan CJ 2006 Islet beta cell failure in type 2 diabetes. Journal of Clinical Investigation 116 1802-1812.
19. Roach JC, Deutsch K, Li S, Siegel AF, Bekris LM, Einhaus DC, Sheridan CM, Glusman G, Hood L, Lernmark A et al. 2006 Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. American Journal of Human Genetics 79 614-627.
20. Srivastava M, Atwater I, Glasman M, Leighton X, Goping G, Caohuy H, Miller G, Pichel J, Westphal H, Mears D et al. 1999 Defects in inositol 1,4,5-trisphosphate receptor expression, Ca(2+) signaling, and insulin secretion in the anx7(+/-) knockout mouse. PNAS 96 13783-13788.
21. Street VA, Bosma MM, Demas VP, Regan MR, Lin DD, Robinson LC, Agnew WS & Tempel BL 1997 The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse. Journal of Neuroscience 17 635-645.
22. 2+ signals.Chaos 19 037102.
23. Vanderheyden V, Devogelaere B, Missiaen L, De Smedt H, Bultynck G & Parys JB 2009 Regulation of inositol 1,4,5-trisphosphate-induced Ca2C release by reversible phosphorylation and dephosphorylation. Biochimica et Biophysica Acta 1793 959-970.
24. Wang M, Wey S, Zhang Y, Ye R & Lee AS 2009 Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxidants and Redox Signaling 11 2307-2316.
25. Xian M, Zhang J & Lau YF 2001 Sry promoters from domesticus (Tirano) and C57BL/6 mice function similarly in embryos and adult animals. Journal of Experimental Zoology 290 632-641.
26. Ye R, Jung DY, Jun JY, Li J, Luo S, Ko HJ, Kim JK & Lee AS 2010a Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 59 6-16.
27. Ye R, Mareninova OA, Barron E,Wang M, Hinton DR, Pandol SJ & Lee AS 2010b Grp78 heterozygosity regulates chaperone balance in exocrine pancreas with differential response to cerulein-induced acute pancreatitis. American Journal of Pathology 177 2827-2836.